Accepted at 1:32 p.m. Dec, 20, 2023 by Ahmed7
Author: shahar
Related Note: 1488768055086
Rationale for change

Direct thrombin inhibitor ARE NOT treatment for HIT!

Treatment is when you treat a disease (exm: Loop's diuretic is treatment for Hypertention")

You treat HIT with: STOP the heparin and replace it with Direct thrombin inhibitor

So its better to say "What class of anticoagulants are used for the managment of heparin-induced thrombocytopenia (HIT)?

Text Text
Extra
e.g., argatroban, dabigatran, bivalirudin

Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy


Watch Quantitative Platelet Disorders
Sketchy 2





Watch DVT SOAP
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize




Watch Direct Thrombin Inhibitors (Argatroban, Dabigatran, Bivalirudin)
Physeo

Bootcamp
Watch associated Bootcamp video - Coagulation and Fibrinolysis: Anticoagulation
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#AMBOSS::z4arNk #PANCE::HEME::coagulation_disorders #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::04_Direct_Thrombin_Inhibitors_(Argatroban/Dabigatran/Bivalirudin) #AK_Step1_v12::#UWorld::COMLEX::24189 #AK_Step1_v12::#B&B::11_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Step2_v12::#Resources_by_rotation::Surgery::nbme::form_6 #AK_Step2_v12::#UWorld::Step::2250 #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #AK_Step2_v12::!Shelf::Surgery::no_dupes #AK_Step2_v12::#AMBOSS::uT0ps2 #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::thrombocytopenia #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#AMBOSS #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::09_Thrombocytopenia #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc !AK_UpdateTags::AnKing_Image::AhmedA #AK_Step2_v12::#AMBOSS::Bx0zAR !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Thrombocytopenia #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::01_Heparin,_LMWH,_fondaparinux,_direct_thrombin_inhibitors,_Xa_inhibitors #AK_Step3_v12::#UWorld::5293 #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::01_Quantitative_Platelet_Disorders #AK_Step1_v12::#UWorld::Step::1078 #AK_Step1_v12::#USMLERx::3462.12 #AK_Step2_v12::#Resources_by_rotation::Surgery::emma #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::02_Heparin #AK_Step2_v12::Original_decks::Dorian::surg::emma #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::#AMBOSS::7T04H2 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::02_DirectThrombinInhibitors_DirectFactorXaInhibitors #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::04_Direct_coagulation_factor_inhibitors::*Direct_Thrombin_Inhibitors #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step2_v12::#UWorld::COMLEX::28068 #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::thrombocytopenia